Spectroscopic investigations of the molecular interaction of anticancer drug mitoxantrone with non-ionic surfactant micelles

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 5, 2012, Pages 688-696

  Enache, Mirela ^a   Volanschi, Elena ^b  

^a INSTITUTE OF PHYSICAL CHEMISTRY   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

absorption spectroscopy; binding constant; mitoxantrone; non ionic surfactant micelles; partition coefficient

Indexed keywords

MITOXANTRONE; MONOMER; NONIONIC SURFACTANT; POLYSORBATE 20; POLYSORBATE 80; TRITON X 100;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; DRUG BINDING; DRUG STRUCTURE; ENCAPSULATION; HYDROPHOBICITY; MEMBRANE BINDING; MICELLE; MOLECULAR INTERACTION; PARTITION COEFFICIENT; PH; PROTON TRANSPORT; SPECTROSCOPY; ULTRAVIOLET VISIBLE ABSORPTION SPECTROSCOPY;

DIMERIZATION; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MEMBRANES; MICELLES; MITOXANTRONE; MODELS, BIOLOGICAL; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE-ACTIVE AGENTS; WATER;

EID: 84859567969     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01445.x     Document Type: Article

References (49)

1. Caetano W, Tabak M,. Interaction of chlorpromazine and trifluoroperazine with ionic micelles: electronic absorption spectroscopy studies. Spectrochim Acta A 1999; 55: 2513-2252.
2. Erdinc N, et al,. Interaction of epirubicin HCl with surfactants: effect of NaCl and glucose. J Pharm Sci 2004; 93: 1566-1575.
3. Chakraborty H, Sarkar M,. Interaction of piroxicam with micelles: effect of hydrophobic chain length on structural switchover. Biophys Chem 2005; 117: 79-85.
4. Cudina O, et al,. Interaction of hydrochlorothiazide with cationic surfactant micelles of cetyltrimethylammonium bromide. Colloids Surf A: Physicochem Eng Aspects 2005; 256: 225-232.
5. Akhtar F, et al,. Interaction of cefadroxyl monohydrate with hexadecyltrimethyl ammonium bromide and sodium dodecyl sulfate. J Chem Thermodyn 2008; 40: 1082-1086.
6. Engberts JBFN, Hoekstra D,. Vesicle-forming synthetic amphiphiles. Biochim Biophys Acta 1995; 1241: 323-340.
7. Cudina O, et al,. Study of valsartan interaction with micelles as a model for biomembranes. Colloids Surf B Biointerfaces 2008; 65: 80-84.
8. Rangel-Yagui CO, et al,. Micellar solubilization of drugs. J Pharm Pharm Sci 2005; 8: 147-163.
9. Narang AS, et al,. Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007; 345: 9-25.
10. Khossravi D,. Drug-surfactant interactions: effect on transport properties. Int J Pharm 1997; 155: 179-190.
11. Doughty JC, et al,. Mitoxantrone and methotrexate chemotherapy with and without mitomycin C in the regional treatment of locally advanced breast cancer. Breast 2002; 11: 97-99.
12. Nowoselac AV, et al,. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia 2004; 18: 1561-1562.
13. Hagemeister F, et al,. The role of mitoxantrone in the treatment of indolent lymphomas. Oncologist 2005; 10: 150-159.
14. Pommier Y, et al,. Effect of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochemistry 1985; 24: 6406-6410.
15. Benjamin RS,. Rationale for the use of mitoxantrone in the older patient: cardiac toxicity. Semin Oncol 1995; 22: 11-13.
16. Murray TJ,. The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks? Expert Opin Drug Saf 2006; 5: 265-274.
17. Adlakha-Hutcheon G, et al,. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol 1999; 17: 775-779.
18. Ma Y, et al,. pH-responsive mitoxantrone (MX) delivery using mesoporous silica nanoparticels (MSN). J Mater Chem 2011; 21: 9483-9486.
19. Ugwu S, et al,. Preparation, characterization, and stability of liposome-based formulations of mitoxantrone. Drug Dev Ind Pharm 2005; 31: 223-229.
20. Li C, et al,. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone. Int J Pharm 2008; 362: 60-66.
21. Torchilin VP,. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001; 73: 137-172.
22. Enache M, et al,. Coupled spectral and electrochemical evaluation of the anticancer drug mitoxantrone-sodium dodecyl sulfate interaction. Int J Pharm 2010; 390: 100-106.
23. Enache M, Volanschi E,. Spectral studies on the molecular interaction of anticancer drug mitoxantrone with CTAB micelles. J Pharm Sci 2011; 100: 558-565.
24. Rosenberg LS, et al,. The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation. Biochemistry 1986; 25: 1002-1008.
25. Gokturk S, Tuncay M,. Spectral studies of safranin-O in different surfactant solutions. Spectrochim Acta A 2003; 59: 1857-1866.
26. Samsonoff C, et al,. The use of Coomassie brilliant blue for critical micelle concentration determination of detergents. J Colloid Interface Sci 1986; 109: 325-329.
27. Patist A, et al,. On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants. J Surfact Deterg 2000; 3: 53-58.
28. Ballard RE, Park CH,. Optical absorption band shapes of acridine orange, thionine and methylene blue in monomeric and dimeric states. J Chem Soc 1970; 92: 1340-1343.
29. Volanschi E, Vajan L-E,. Spectral investigation of the binding of doxorubicin to calf-thymus DNA. Rev Roum Chim 2001; 46: 163-173.
30. Davies DB, et al,. 1H NMR investigation of self-association of aromatic drug molecules in aqueous solution-structural and thermodynamical analysis. J Chem Soc Faraday Trans 1996; 92: 383-390.
31. Enache M, Volanschi E,. Spectral characterization of self-association of antitumor drug mitoxantrone. Rev Roum Chim 2010; 55: 255-262.
32. Agrawal P, et al,. Studies on self-aggregation of anthracycline drugs by restrained molecular dynamics approach using nuclear magnetic resonance spectroscopy supported by absorption, fluorescence, diffusion ordered spectroscopy and mass spectrometry. Eur J Med Chem 2009; 44: 1437-1451.
33. Evstigneev MP, et al,. Self-association of daunomycin antibiotic in various buffer solutions. Russ J Phys Chem 2006; 80: 741-746.
34. Mahoney BP, et al,. Tumor acidity, ion trapping and chemotherapeutics I. Acid pH affects the distribution of chemotherapeutica agents in vivo. Biochem Pharmacol 2003; 66: 1207-1218.
35. Raghunand N, et al,. Tumor acidity, ion trapping and chemotherapeutics II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 2003; 66: 1219-1229.
36. Siegfried JM, et al,. Cellular transport of anthracyclines by passive diffusion. Biochem Pharmacol 1985; 34: 593-598.
37. Feofanov A, et al,. Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis. Biophys J 1997; 73: 3317-3327.
38. Shen X, et al,. Study of the interactions between substituted 2,2'-bithiophenes and cyclodextrins. Chem Phys Lett 1998; 298: 201-210.
39. Acharya KR, et al,. The surfactant concentration-dependent behaviour of safranine T in Tween (20, 40, 60, 80) and Triton X-100 micellar media. J Photochem Photobiol 1997; 109: 29-34.
40. Sepulveda L, et al,. Interactions of neutral molecules with ionic micelles. Adv Colloid Interface Sci 1986; 25: 1-57.
41. Kawamura H, et al,. Partititon coefficients of homologous ω-phenylalkanols between water and sodium dodecyl sulfate micelles. J Phys Chem 1989; 93: 5536-5540.
42. Reynolds JA, Stoeckenius W,. Molecular weight of bacteriorhodopsin solubilized in Triton X-100. Proc Natl Acad Sci U S A 1977; 74: 2803-2804.
43. Garstecki P, et al,. Nonlinear dynamics of a flow-focusing bubble generator: an inverted dripping faucet. Phys Rev Lett 2005; 94: 234502-234504.
44. Hillgren A, et al,. Interaction between lactate dehydrogenase and Tween 80 in aqueous solution. Pharm Res 2002; 19: 105-110.
45. Burns CP, et al,. Membrane lipid alteration: effect on cellular uptake of mitoxantrone. Lipids 1988; 23: 393-397.
46. Datta A, et al,. Solvation dynamics in organized assemblies 4-aminophthalimide in micelles. J Mol Liq 1998; 77: 121-129.
47. Cevc G, Marsh D,. Phospholipid Bilayers: Physical Principles and Models. New York: John Wiley & Sons, 1987.
48. Mukerjee P, Cardinal JR,. Benzene derivatives and naphthalene solubilized in micelles. Polarity of microenvironments, location and distribution in micelles, and correlation with surface activity in hydrocarbon-water systems. J Phys Chem 1978; 82: 1620-1627.
49. Singh SK, Kishore N,. Volumetric properties of amino acids and hen-egg white lysozyme in aqueous Triton X-100 at 298.15 K. J Solution Chem 2004; 33: 1411-1427.